CCL19

CCL19 Overview

English NameC-C motif chemokine 19Approved Drugs0
Drugs in Clinical Trials1Target SynonymBeta-chemokine exodus-3,CK beta-11,Epstein-Barr virus-induced molecule 1 ligand chemokine,EBI1 ligand chemokine,ELC,Macrophage inflammatory protein 3 beta,MIP-3-beta,Small-inducible cytokine A19,MIP3B,SCYA19
Highest Development StagePhase 1 Clinical
English NameC-C motif chemokine 19
Target SynonymBeta-chemokine exodus-3,CK beta-11,Epstein-Barr virus-induced molecule 1 ligand chemokine,EBI1 ligand chemokine,ELC,Macrophage inflammatory protein 3 beta,MIP-3-beta,Small-inducible cytokine A19,MIP3B,SCYA19
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

CCL19 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Tag Free (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
CC9-H5215
Human
HEK293
Human CCL19 / MIP-3 beta Protein, Tag Free (HPLC verified)
Total: 1
  • 1

CCL19 Background

C-C motif chemokine 19(CCL19) is as known as CK beta-11, ELC, MIP3B and SCYA19. May play a role not only in inflammatory and immunological responses but also in normal lymphocyte recirculation and homing. May play an important role in trafficking of T-cells in thymus, and T-cell and B-cell migration to secondary lymphoid organs. Binds to chemokine receptor CCR7. Recombinant CCL19 shows potent chemotactic activity for T-cells and B-cells but not for granulocytes and monocytes. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4.

CCL19 Synonyms

CCL19,MIP-3 beta,MIP-3-beta,ELC,MIP3B,SCYA19,EBI1 ligand chemokine

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine)Phase 1 ClinicalGuangdong Zhaotai Invivo Biomedicine Co Ltd, Hunan Zhaotai Yongren Biotech Co LtdCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
Details
  • Overview
  • Product List
  • Clinical Drug Information